A New Strategy to Identify ceRNA-Based CCDC144NL-AS1/SERPINE1 Regulatory Axis as a Novel Prognostic Biomarker for

Zhihong Huang1, Xinkui Liu1, Chao Wu1

  • 1Department of Clinical Pharmacology of Traditional Chinese Medicine, School of Chinese Materia Medica, Beijing University of Chinese Medicine, Beijing, China.

Frontiers in Oncology
|February 14, 2022
PubMed

Related Concept Videos